Emles @Home ETF
LIV
LIV was delisted on the 19th of October, 2022.
2 hedge funds and large institutions have $4.2M invested in Emles @Home ETF in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
9% more capital invested
Capital invested by funds: $3.84M → $4.2M (+$364K)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.29K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Goldman Sachs
New York
| $4.2M | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $3K | +$2.29K | +87 | +311% |
|
LIV Hedge Fund Activity: Q2 2021 in Review
2 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Emles @Home ETF (LIV) for Q2 2021, worth a combined $4.2M — up 9.5% from $3.84M a quarter earlier.
Fund positioning in LIV was balanced in Q2 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $2.29K.
- 2 institutional investors held Emles @Home ETF (LIV) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $4.2M of Emles @Home ETF stock for Q2 2021, up 9.5% quarter-over-quarter.
- 0 funds opened new Emles @Home ETF positions in Q2 2021 and 0 closed out.
- The largest Emles @Home ETF buyer in Q2 2021 was UBS Group, an estimated $2.29K added.
Based on aggregated 13F filings for Q2 2021.